Gland Pharma COO Satnam Singh Loomba to Step Down
Written By : sheeba farhat
Published On 2026-02-01 04:30 GMT | Update On 2026-02-01 04:30 GMT
Advertisement
New Delhi: Gland Pharma Limited has informed stock exchanges that Satnam Singh Loomba, Chief Operating Officer (COO) of the company, will retire from his position with effect from the close of business hours on March 31, 2026, upon attaining superannuation.
In a regulatory filing made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company stated that Loomba will also cease to be part of the Senior Management Personnel from the same date.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.